C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study
- 1Department of Allergy, Respiratory Medicine and Sleep, Landspitali University Hospital, 108 Reykjavik, Iceland
- 2Department of Gastroenterology, Landspitali University Hospital, 101 Reykjavik, Iceland
- 3Department of Clinical Biochemistry, Landspitali University Hospital, 108 Reykjavík, Iceland
- 4Lung Clinic, Tartu University Clinics, Estonia
- 5Department of Medical Sciences: Respiratory Medince and Allergology, Uppsala University, Sweden
- Correspondence to:
Professor T Gislason
Department of Allergy, Respiratory Medicine and Sleep, Landspitali University Hospital, 108 Reykjavík, Iceland; thorariglandspitali.is
- Received 19 October 2004
- Accepted 10 February 2005
Abstract
Background: High sensitivity C reactive protein (HsCRP) is an inflammatory marker known to be related to smoking, obesity, and cardiovascular disease. A study was undertaken to determine whether HsCRP is related to respiratory symptoms, asthma, atopy, and bronchial hyperresponsiveness in population samples from three countries.
Methods: HsCRP was measured in 1289 subjects from three centres in ECRHS II: Reykjavik, Uppsala and Tartu. The HsCRP values ranged from <0.01 mg/l to 70.0 mg/l and were divided into four equal groups (≤0.45, 0.46–0.96, 0.97–2.21, and >2.21 mg/l).
Results: HsCRP increased with increasing body mass index (r = 0.41; p<0.0001) and was higher in smokers than in never smokers (p = 0.02). A significant relationship was found between increased HsCRP levels and respiratory symptoms such as wheeze, attacks of breathlessness after effort, and nocturnal cough (p<0.0001). The crude odds ratio (95% CI) for the probability of non-allergic asthma was 3.57 (1.83 to 6.96) for subjects in the 4th quartile compared with the 1st quartile of HsCRP. This association remained significant after adjusting for study centre, age, sex, body weight, and smoking history (OR 2.19 (95% CI 1.04 to 4.63)). No significant relationship was observed between HsCRP and allergic asthma or bronchial responsiveness.
Conclusions: Raised levels of HsCRP are significantly associated with respiratory symptoms and non-allergic asthma but not with allergic asthma.
Footnotes
-
The study was supported financially by the Icelandic Research Council, the Swedish Heart and Lung Foundation, the Vårdal Foundation for Health Care Science and Allergy Research, the Swedish Association Against Asthma and Allergy, and the Estonian Science Foundation grant no 4350.









